Table 2.
Demographic and clinical characteristics of patients and levels of CPNE1 protein expression in NSCLC tissue.
| Characteristics | n = 14 | CPNE1 protein expression high (n = 10) low (n = 4) | P value | |
|---|---|---|---|---|
| Age (years) | ||||
| ≤60 | 5 (35.7%) | 2 | 3 | 0.095 |
| >60 | 9 (64.3%) | 8 | 1 | |
| Gender | ||||
| Male | 9 (64.3%) | 6 | 3 | 0.545 |
| Female | 5 (35.7%) | 4 | 1 | |
| Histological features | ||||
| Adenocarcinoma | 12 (85.7%) | 9 | 3 | 0.505 |
| Squamous cell carcinoma | 2 (14.3%) | 1 | 1 | |
| Smoker | ||||
| Yes | 9 (64.3%) | 7 | 2 | 0.706 |
| No | 5 (35.7%) | 3 | 2 | |
| Clinical stage | ||||
| I +II | 5 (35.7%) | 4 | 1 | 0.545 |
| III + IV | 9 (64.3%) | 6 | 3 | |
| Distant metastasis | ||||
| No | 12 (85.7%) | 10 | 2 | / |
| Yes | 2 (14.3%) | 0 | 2 | |
| Lymph node metastasis | ||||
| No | 5 (35.7%) | 4 | 1 | 0.545 |
| Yes | 9 (64.3%) | 6 | 3 | |
Data are presented as the mean ± SD values. The Kruskal–Wallis test was used for comparisons among three or more groups.